Psychological Impairment Due to Covid-19

May 5, 2021 updated by: University Hospital, Essen

Psychological Impairment Due to Covid-19 in Hospital Staff

Hospital staff and emergency personnel are expected to suffer impaired psychological outcomes during a pandemic in terms of Quality of Life, anxiety, depression or other outcomes. The Covid-19 pandemic is a threat for both somatic and psychological health, therefore the impact of the impairment of this event on psychological parameters has to be assessed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Hospital staff and emergency personell are confronted with severe and life-threatening situations, therefore this group is considered to be at risk for impaired psychological health. A pandemic such as the Covid-19 endemic is suggested to severely impair the psychological state of this profession, amongst others Quality of life, anxiety, depression and other parameters. Therefore, it is crucial to assess the impact of impairment due to this global threat on the psychological health of health care providers. We therefore designed this study to evaluate baseline psychological characteristics and to re-assess those values in an interval of 60 days.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • NRW
      • Essen, NRW, Germany, 45147
        • University Hospital Essen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Inclusion of all persons which can be attributed to hospital stuff, those include doctors and nurses (male/female)

Description

Inclusion Criteria:

Hospital staff (doctors and nurses)

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Health care providers/hospital staff
The targeted group are doctors and nurses (hospital stuff) of a large university hospital directly confronted with patients with Cov-19
Other: No intervention
No intervention, just of questionnaire including validated tests

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PCL5 Questionnaire
Time Frame: 14 days
Validated 20-items questionnaire for PTSD
14 days
BSI - Brief symptom inventory
Time Frame: 14 days
The Brief Symptom Inventory (BSI) is a 53-item screener for mental health problems with 9 subscales.
14 days
PHQD
Time Frame: 14 days
Instrument for psychological diagnostics, able to test the severity of mental disorders and the success of their treatment
14 days
WHO - QoL BREF
Time Frame: 14 days
Qol Questionnaire, assessed QoL with respect to the individual's perceptions in the context of culture and value systems.
14 days
STAXI
Time Frame: 14 days
The State-Trait Anger Expression Inventory is used to measure the expressions & control of anger
14 days
AUDIT questionnaire
Time Frame: 14 days
The AUDIT questionnaire is designed to help in the self assessment of alcohol consumption
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Essen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2020

Primary Completion (Actual)

September 30, 2020

Study Completion (Actual)

December 30, 2020

Study Registration Dates

First Submitted

April 9, 2020

First Submitted That Met QC Criteria

April 28, 2020

First Posted (Actual)

April 29, 2020

Study Record Updates

Last Update Posted (Actual)

May 6, 2021

Last Update Submitted That Met QC Criteria

May 5, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • TEMP553914-BO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on No intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe